GNRH1 and polycystic ovary syndrome: Studies suggest that naltrexone results in weight reduction and is closely associated with LH and LH/FSH ratio reduction in clomiphene-resistant PCOS women, while enhancing ovulation rates when combined with pulsatile GnRH infusion62–64.